Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism CAMKK2 agonists(calcium/calmodulin dependent protein kinase kinase 2 agonists), PRKAA1 agonists(protein kinase AMP-activated catalytic subunit alpha 1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Intestinal Diseases | Preclinical | South Korea | 05 Dec 2025 | |
| Intestinal Diseases | Preclinical | South Korea | 05 Dec 2025 |





